HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study
- PMID: 29568639
- PMCID: PMC5843078
- DOI: 10.4102/sajhivmed.v18i1.732
HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study
Abstract
Introduction: HIV-associated neurocognitive disorder (HAND) is a consequence of HIV infection of the central nervous system. The prevalence ranges between 15% and 60% in different settings.
Objectives: This prospective study determined the prevalence of HAND at a peri-urban HIV clinic in KwaZulu-Natal. Factors associated with HAND were examined, alternate neurocognitive tools were tested against the international HIV dementia scale (IHDS) score and an association between HAND and non-adherence to antiretroviral therapy (ART) was explored.
Methods: Between May 2014 and May 2015, 146 ART-naïve outpatients were assessed for HAND. IHDS score ≤ 10 established a diagnosis of HAND. Functional capacity was assessed using Eastern Cooperative Oncology Group (ECOG) score. Chi-squared test was used to identify risk factors for HAND. The get-up-and-go test (GUGT) and Center for Epidemiological Studies Depression scale - revised (CESD-r) were tested against the IHDS. HIV viral load done six months after initiating ART was used as a surrogate marker for adherence to ART.
Results: The prevalence of HAND was 53%. In total, 99.9% of patients with HAND had no functional impairment. Age > 50 years old was associated with HAND (p = 0.003). There was no correlation between the GUGT, CESD-r and the IHDS score. HAND was not associated with non-adherence (p = 0.06).
Conclusions: While the prevalence of HAND is high, it is not associated with functional impairment which suggests that asymptomatic neurocognitive impairment is prevalent. Age > 50 years old is a risk factor for HAND. The GUGT and CESD-r are not useful diagnostic tools for HAND. The relationship between HAND and non-adherence should be further explored.
Conflict of interest statement
J.C.M., D.W. and A.M. report no disclosures. H.D. has received honoraria from MSD, Pfizer and Novartis, South Africa, for speaking engagements and has received a travel grant from Novartis and Myalan, South Africa.
Figures


Similar articles
-
Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):278-283. doi: 10.1097/QAI.0000000000002257. J Acquir Immune Defic Syndr. 2020. PMID: 32032278 Free PMC article.
-
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.PLoS One. 2016 Dec 19;11(12):e0168225. doi: 10.1371/journal.pone.0168225. eCollection 2016. PLoS One. 2016. PMID: 27992497 Free PMC article.
-
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.BMC Infect Dis. 2019 Feb 13;19(1):156. doi: 10.1186/s12879-019-3784-y. BMC Infect Dis. 2019. PMID: 30760220 Free PMC article.
-
International HIV Dementia Scale for HIV-Associated Neurocognitive Disorders: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2021 Jun 20;11(6):1124. doi: 10.3390/diagnostics11061124. Diagnostics (Basel). 2021. PMID: 34202994 Free PMC article. Review.
-
Worldwide Occurrence of HIV-Associated Neurocognitive Disorders and Its Associated Factors: A Systematic Review and Meta-Analysis.Front Psychiatry. 2022 May 31;13:814362. doi: 10.3389/fpsyt.2022.814362. eCollection 2022. Front Psychiatry. 2022. PMID: 35711575 Free PMC article.
Cited by
-
A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa.South Afr J HIV Med. 2024 Jul 22;25(1):1579. doi: 10.4102/sajhivmed.v25i1.1579. eCollection 2024. South Afr J HIV Med. 2024. PMID: 39113780 Free PMC article.
-
Neurocognitive functioning in MDR-TB patients with and without HIV in KwaZulu-Natal, South Africa.Trop Med Int Health. 2020 Aug;25(8):919-927. doi: 10.1111/tmi.13444. Epub 2020 Jun 16. Trop Med Int Health. 2020. PMID: 32428324 Free PMC article.
-
Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics.Int J Mol Sci. 2018 Nov 14;19(11):3594. doi: 10.3390/ijms19113594. Int J Mol Sci. 2018. PMID: 30441796 Free PMC article. Review.
-
Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral Genotype.J Int Neuropsychol Soc. 2020 Jul;26(6):607-623. doi: 10.1017/S1355617720000120. Epub 2020 Feb 18. J Int Neuropsychol Soc. 2020. PMID: 32066518 Free PMC article.
-
Functioning Problems Associated with Health Conditions with Greatest Disease Burden in South Africa: A Scoping Review.Int J Environ Res Public Health. 2022 Nov 24;19(23):15636. doi: 10.3390/ijerph192315636. Int J Environ Res Public Health. 2022. PMID: 36497710 Free PMC article.
References
-
- Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13(11):976–986. https://doi.org/10.1016/S1473-3099(13)70269-X - DOI - PMC - PubMed
-
- Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I. HIV-associated neurocognitive disorders (HAND). Isr Med Assoc J. 2015;17(1):54–59. - PubMed
-
- Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol. 2011;24(3):275–283. https://doi.org/10.1097/WCO.0b013e32834695fb - DOI - PMC - PubMed
-
- Nightingale S, Winsto A, Letendre S, et al. . Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139–1151. https://doi.org/10.1016/S1474-4422(14)70137-1 - DOI - PMC - PubMed
-
- Robinson-Papp J, Elliott KJ, Simpson DM. HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep. 2009;6(3):146–152. https://doi.org/10.1007/s11904-009-0020-1 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources